Showing 1 - 20 results of 44 for search 'Carlo Gambacorti Passerini', query time: 0.06s Refine Results
  1. 1
    How “precise” is precision medicine in hematology?

    How “precise” is precision medicine in hematology? by Carlo Gambacorti-Passerini, Rocco Piazza

    Published 2017-01-01
    Get full text
    Article
  2. 2
    Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

    Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia by Diletta Fontana, Carlo Gambacorti-Passerini, Carlo Gambacorti-Passerini, Rocco Piazza, Rocco Piazza, Rocco Piazza

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage

    Impact of ETNK1 somatic mutations on phosphoethanolamine synthesis, ROS production and DNA damage by Diletta Fontana, Carlo Gambacorti-Passerini, Rocco Piazza

    Published 2021-03-01
    Get full text
    Article
  4. 4
    Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells.

    Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells. by Luca Mologni, Stefania Brussolo, Monica Ceccon, Carlo Gambacorti-Passerini

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib

    Alterations in creatine kinase, phosphate and lipid values in patients with chronic myeloid leukemia during treatment with imatinib by Anna Franceschino, Lucia Tornaghi, Valerie Benemacher, Sarit Assouline, Carlo Gambacorti-Passerini

    Published 2008-02-01
    Get full text
    Article
  6. 6
    Can Similarities between the Pathogenesis of Preeclampsia and COVID-19 Increase the Understanding of COVID-19?

    Can Similarities between the Pathogenesis of Preeclampsia and COVID-19 Increase the Understanding of COVID-19? by Valentina Giardini, Carlo Gambacorti-Passerini, Marco Casati, Andrea Carrer, Patrizia Vergani

    Published 2022-05-01
    Get full text
    Article
  7. 7
    Analogies between COVID-19 and Preeclampsia: Focus on Therapies

    Analogies between COVID-19 and Preeclampsia: Focus on Therapies by Valentina Giardini, Carlo Gambacorti-Passerini, Marco Casati, Andrea Carrer, Patrizia Vergani

    Published 2023-04-01
    Get full text
    Article
  8. 8
    PB2182: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AT DIAGNOSIS IN ESSENTIAL THROMBOCYTEMIA (ET): A NEW PREDICTOR OF THROMBOTIC EVENTS

    PB2182: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AT DIAGNOSIS IN ESSENTIAL THROMBOCYTEMIA (ET): A NEW PREDICTOR OF THROMBOTIC EVENTS by Alessia Ripamonti, Fabrizio Cavalca, Elena Agostani, Carlo Gambacorti-Passerini, Elena Maria Elli

    Published 2023-08-01
    Get full text
    Article
  9. 9
    An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization

    An Imatinib–non‐responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization by Ilaria Crespiatico, Elisa Bossi, Filippo Brioschi, Rocco Piazza, Luca Mologni, Carlo Gambacorti‐Passerini

    Published 2020-01-01
    Get full text
    Article
  10. 10
    Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization

    Single‐center study on SARS‐CoV‐2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization by Ivan Civettini, Laura Antolini, Filippo Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti‐Passerini

    Published 2023-04-01
    Get full text
    Article
  11. 11
    PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES

    PB1879: EFFICACY AND SAFETY OF CPX-351 COMPARED TO STANDARD OF CARE CHEMOTHERAPY IN A REAL-LIFE SETTING: SUPPORTING PREVIOUS EVIDENCE AND FACING NEW CHALLENGES by Beatrice Manghisi, Sara Alberti, Alessia Ripamonti, Paola Perfetti, Lorenza Maria Borin, Monica Fumagalli, Carlo Gambacorti Passerini

    Published 2023-08-01
    Get full text
    Article
  12. 12
    PB1976: SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION.

    PB1976: SINGLE CENTER STUDY ON SARS-COV-2 INFECTION IN PATIENTS AFFECTED BY CML: VACCINATION STATUS AND BOSUTINIB THERAPY AS POSSIBLE PROTECTIVE FACTORS FOR HOSPITALIZATION. by Ivan Civettini, Laura Antolinni, Filippo Achille Brioschi, Giovanni Paolo Maria Zambrotta, Veronica Guglielmana, Carlo Gambacorti-Passerini

    Published 2023-08-01
    Get full text
    Article
  13. 13
    P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES

    P1056: NEXT GENERATION SEQUENCING IDENTIFIES SUBGROUPS OF PATIENTS WITH TRIPLE NEGATIVE/ PRIMARY THROMBOCYTOSIS WITH DIFFERENT CLINICAL OUTCOMES by Valentina Sangiorgio, Rocco Giovanni Piazza, Federica Mottadelli, Fabio Pagni, Inzoli Elena, Carlo Gambacorti-Passerini, Gianni Cazzaniga, Elena Maria Elli

    Published 2023-08-01
    Get full text
    Article
  14. 14
    P1175: THROMBOTIC RISK IN DLBCL: A REAL-LIFE COMPARISON OF THE THROLY AND MODEL IX SCORES

    P1175: THROMBOTIC RISK IN DLBCL: A REAL-LIFE COMPARISON OF THE THROLY AND MODEL IX SCORES by Ivan Civettini, Fabrizio Cavalca, Arianna Zappaterra, Stefano Crippa, Elena Agostani, Andrea Palasciano, Laura Antolinni, Federica Cocito, Carlo Gambacorti-Passerini

    Published 2023-08-01
    Get full text
    Article
  15. 15
    PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS

    PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS by Susanne Isfort, Carlo Gambacorti-Passerini, Tim H Brümmendorf, B. Douglas Smith, Simon Purcell, Huadong Zhao, Luke Kuttschreuter, Jane Apperley

    Published 2023-08-01
    Get full text
    Article
  16. 16
    Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection

    Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 Infection by Valentina Giardini, Sara Ornaghi, Carlo Gambacorti-Passerini, Marco Casati, Andrea Carrer, Eleonora Acampora, Maria Viola Vasarri, Francesca Arienti, Patrizia Vergani

    Published 2022-10-01
    Get full text
    Article
  17. 17
    Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection

    Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection by Valentina Giardini, Sara Ornaghi, Eleonora Acampora, Maria Viola Vasarri, Francesca Arienti, Carlo Gambacorti-Passerini, Marco Casati, Andrea Carrer, Patrizia Vergani

    Published 2021-11-01
    Get full text
    Article
  18. 18
    Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review

    Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review by Jorge E. Cortes, Jane F. Apperley, Daniel J. DeAngelo, Michael W. Deininger, Vamsi K. Kota, Philippe Rousselot, Carlo Gambacorti-Passerini

    Published 2018-12-01
    Get full text
    Article
  19. 19
    Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study

    Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study by Jorge E. Cortes, Jeff H. Lipton, Vamsi Kota, Fausto Castagnetti, Sarit Assouline, Tim H. Brümmendorf, Eric Leip, Andrea Viqueira, Carlo Gambacorti-Passerini

    Published 2023-07-01
    Get full text
    Article
  20. 20
    CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data.

    CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data. by Rocco Piazza, Vera Magistroni, Alessandra Pirola, Sara Redaelli, Roberta Spinelli, Serena Redaelli, Marta Galbiati, Simona Valletta, Giovanni Giudici, Giovanni Cazzaniga, Carlo Gambacorti-Passerini

    Published 2013-01-01
    Get full text
    Article

Search Tools: